Related references
Note: Only part of the references are listed.A novel controlled release tetrandrine-loaded PDLLA film: evaluation of drug release and anti-adhesion effects in vitro and in vivo
Hai Yao et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma
Xue-Tao Li et al.
JOURNAL OF LIPOSOME RESEARCH (2019)
Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1/2 signaling pathway
Fu-Zhen Lin et al.
PHYTOMEDICINE (2019)
Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles
Xiao Que et al.
DRUG DELIVERY (2019)
Potential of Fatty Oils from Traditional Chinese Medicine in Cancer Therapy: A Review for Phytochemical, Pharmacological and Clinical Studies
Yanleng Huang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
The American Cancer Society 2035 challenge goal on cancer mortality reduction
Jiemin Ma et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Tetrandrine isolated from Cyclea peltata induces cytotoxicity and apoptosis through ROS and caspase pathways in breast and pancreatic cancer cells
N. Bhagya et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2019)
Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells
Huimin Zou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Focus on Formononetin: Anticancer Potential and Molecular Targets
Samantha Kah Ling Ong et al.
CANCERS (2019)
Tetrandrine induces apoptosis in human neuroblastoma through regulating the Hippo/YAP signaling pathway
Qian Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Natural products: An upcoming therapeutic approach to cancer
Sayanta Dutta et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Synthesis, purification, and anticancer effect of magnetic Fe3O4-loaded poly (lactic-co-glycolic) nanoparticles of the natural drug tetrandrine
Kaiping Wang et al.
JOURNAL OF MICROENCAPSULATION (2019)
Advances in exploring the therapeutic potential of marine natural products
Xiao Liang et al.
PHARMACOLOGICAL RESEARCH (2019)
Formononetin: A Review of Its Anticancer Potentials and Mechanisms
Kai-Ching Tay et al.
FRONTIERS IN PHARMACOLOGY (2019)
Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells
Wencheng Xu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics
Iliyas Khan et al.
PHARMACEUTICAL RESEARCH (2019)
Cancer Metabolism and the Evasion of Apoptotic Cell Death
Aditi Sharma et al.
CANCERS (2019)
Inhibition of laryngeal cancer stem cells by tetrandrine
Xiangyan Cui et al.
ANTI-CANCER DRUGS (2019)
Targeting the Ca2+/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cells
Tracy Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Vincristine ablation of Sirt2 induces cell apoptosis and mitophagy via Hsp70 acetylation in MDA-MB-231 cells
Fanghui Sun et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro
Yi-Wen Jiang et al.
ENVIRONMENTAL TOXICOLOGY (2019)
Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling
Yubo Guo et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Tetrandrine, a novel inhibitor of ether-a-go-go-1 (Eag1), targeted to cervical cancer development
Xuzhao Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Enhancing tetrandrine cytotoxicity in human lung carcinoma A549 cells by suppressing mitochondrial ATP production
Louis W. C. Chow et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Curcumin in combination with anti-cancer drugs: A nanomedicine review
Harshul Batra et al.
PHARMACOLOGICAL RESEARCH (2019)
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo
Haiyan Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Curcumin and Gastric Cancer: a Review on Mechanisms of Action
Tohid Hassanalilou et al.
JOURNAL OF GASTROINTESTINAL CANCER (2019)
Scutellaria baicalensis and Cancer Treatment: Recent Progress and Perspectives in Biomedical and Clinical Studies
Chien-Shan Cheng et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2018)
Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21(Cip1/Waf1), p27(Kip1) and cyclin D1
Karnika Singh et al.
CANCER LETTERS (2018)
Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity
Junjie Lan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis of novel tetrandrine derivatives and their inhibition against NSCLC A549 cells
Qian-Hao Yang et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2018)
The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells
Zhenxing Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy
Man Yu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors
Stephen J. Capuzzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
H-1 NMR-based metabolomics approach to investigate the urine samples of collagen-induced arthritis rats and the intervention of tetrandrine
Xinming Yun et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Anticancer activity of tetrandrine by inducing pro-death apoptosis and autophagy in human gastric cancer cells
Xin-Yu Bai et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis
Gauri Shishodia et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Modulation of oncogenic transcription factors by bioactive natural products in breast cancer
Mohadeseh Hasanpourghadi et al.
PHARMACOLOGICAL RESEARCH (2018)
A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer
Buse Cevatemre et al.
PHARMACOLOGICAL RESEARCH (2018)
Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
Shunyu Hou et al.
PLOS ONE (2018)
Tetrandrine Enhances Radiosensitization in Human Hepatocellular Carcinoma Cell Lines
Xiao-mei Zhao et al.
RADIATION RESEARCH (2018)
Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents
Junrong Song et al.
MEDCHEMCOMM (2018)
c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation
Guixian Wu et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
Bo Yuan et al.
CANCER CELL INTERNATIONAL (2018)
Tetrandrine inhibits the proliferation and cytokine production induced by IL-22 in HaCaT cells
Fang Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Synthesis and anticancer activity of dimeric podophyllotoxin derivatives
Cheng-Ting Zi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Tetrandrine Induces Programmed Cell Death in Human Oral Cancer CAL 27 Cells Through the Reactive Oxygen Species Production and Caspase-Dependent Pathways and Associated with Beclin-1-Induced Cell Autophagy
Jin-Cherng Lien et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression
Yong Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Design and synthesis of novel tetrandrine derivatives as potential antitumor agents against human hepatocellular carcinoma
Junjie Lan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma
Xiao-li Song et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Tetrandrine cardioprotection in ischemia-reperfusion (I/R) injury via JAK3/ STAT3/Hexokinase II
Tie-jun Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7
Mingjiang Yao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer
Mengjuan Jiang et al.
MOLECULAR PHARMACEUTICS (2017)
Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells
Bo Kou et al.
ONCOLOGY REPORTS (2017)
Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway
Dong-Dong Tian et al.
ONCOLOGY REPORTS (2017)
Identification of sennoside A as a novel inhibitor of the slingshot (SSH) family proteins related to cancer metastasis
Seon Young Lee et al.
PHARMACOLOGICAL RESEARCH (2017)
Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells
Chieh-Hsiang Lu et al.
PHARMACOLOGICAL RESEARCH (2017)
Tetrandrine, an Activator of Autophagy, Induces Autophagic Cell Death via PKC-α Inhibition and mTOR-Dependent Mechanisms
Vincent Kam Wai Wong et al.
FRONTIERS IN PHARMACOLOGY (2017)
Aloe-Emodin Enhances Tamoxifen Cytotoxicity by Suppressing Ras/ERK and PI3K/mTOR in Breast Cancer Cells
Hsin-Shun Tseng et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
Tetrandrine has anti-adipogenic effect on 3T3-L1 preadipocytes through the reduced expression and/or phosphorylation levels of C/EBP-α, PPAR-γ, FAS, perilipin A, and STAT-3 (vol 476, pg 481, 2016)
Byeong-Churl Jang
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation
Ting Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: a retrospective clinical analysis
Xuan Liu et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2017)
Hybrid Prodrug Nanoparticles with Tumor Penetration and Programmed Drug Activation for Enhanced Chemoresistant Cancer Therapy
Caiyan Zhao et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation NSENL Reverses Cisplatin Resistance in Lung Cancer Xenografts
Ling Jin et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents
Dechao Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Tetrandrine induces lipid accumulation through blockade of autophagy in a hepatic stellate cell line
Yusaku Miyamae et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor
Xusheng Yuan et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling
Xia Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-B inactivation
Li-Na Gao et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2016)
Tetrandrine ameliorates sevoflurane-induced cognitive impairment via the suppression of inflammation and apoptosis in aged rats
Hongmei Ma et al.
MOLECULAR MEDICINE REPORTS (2016)
Tetrandrine suppresses -glucan-induced macrophage activation via inhibiting NF-B, ERK and STAT3 signaling pathways
Jing Xu et al.
MOLECULAR MEDICINE REPORTS (2016)
Neuroprotective effects of tetrandrine against vascular dementia
Yan-ling Lv et al.
NEURAL REGENERATION RESEARCH (2016)
Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
R. S. Reshma et al.
PHARMACOLOGICAL RESEARCH (2016)
Bioactive natural products in cancer prevention and therapy: Progress and promise
Anupam Bishayee et al.
SEMINARS IN CANCER BIOLOGY (2016)
The development of a quantitative and qualitative method based on UHPLC-QTOF MS/MS for evaluation paclitaxel-tetrandrine interaction and its application to a pharmacokinetic study
Dan Li et al.
TALANTA (2016)
Tetrandrine induces apoptosis Via caspase-8,-9, and-3 and poly (ADP ribose) polymerase dependent pathways and autophagy through beclin-1/LC3-I, II signaling pathways in human oral cancer HSC-3 cells
Fu-Shun Yu et al.
ENVIRONMENTAL TOXICOLOGY (2016)
Anti-nociceptive, anti-inflammatory and toxicological evaluation of Fang-Ji-Huang-Qi-Tang in rodents
Yu-Chin Lin et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation
Ji-wei Ma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Improved delivery of the natural anticancer drug tetrandrine
Chen Shi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance
Lejiao Jia et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6
Hua Sun et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2015)
Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
Yasuteru Sakurai et al.
SCIENCE (2015)
Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells
Ting Liu et al.
ONCOTARGET (2015)
Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species
Haiqing Wang et al.
CELL AND BIOSCIENCE (2015)
Potent natural products and herbal medicines for treating liver fibrosis
Shao-Ru Chen et al.
CHINESE MEDICINE (2015)
Beneficial effect of tetrandrine on refractory epilepsy via suppressing P-glycoprotein
Yinghui Chen et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)
Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo
Wenkai Xiao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine
Pankaj Chaudhary et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies
Jiawei Li et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2014)
Tetrandrine suppresses pro-inflammatory mediators in PMA plus A23187-induced HMC-1 cells
Ok-Hwa Kang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells
Tao Chen et al.
JOURNAL OF NATURAL MEDICINES (2014)
Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells
Yan Fang Sun et al.
PHYTOMEDICINE (2014)
Antinociceptive Effect of Tetrandrine on LPS-Induced Hyperalgesia via the Inhibition of IKKβ Phosphorylation and the COX-2/PGE2 Pathway in Mice
Hengguang Zhao et al.
PLOS ONE (2014)
Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17
Zhichao Wu et al.
TUMOR BIOLOGY (2014)
Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells
W. Qiu et al.
CELL DEATH & DISEASE (2014)
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Janet L. Markman et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Nanotechnology approaches for personalized treatment of multidrug resistant cancers
Tamara Minko et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Tetrandrine exerts antidepressant-like effects in animal models: Role of brain-derived neurotrophic factor
Shan Gao et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Different strategies to overcome multidrug resistance in cancer
Manju Saraswathy et al.
BIOTECHNOLOGY ADVANCES (2013)
Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling
J. Wan et al.
BRITISH JOURNAL OF CANCER (2013)
Molecular Mechanism Underlying Anti-Inflammatory and Anti-Allergic Activities of Phytochemicals: An Update
Yuva Bellik et al.
MOLECULES (2013)
Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase
Vivian W. L. Yu et al.
ONCOLOGY REPORTS (2013)
Enhanced Topical Delivery of Tetrandrine by Ethosomes for Treatment of Arthritis
Chao Fan et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line
Jian Cheng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Autophagy-related Gene 7 (ATG7) and Reactive Oxygen Species/Extracellular Signal-regulated Kinase Regulate Tetrandrine-induced Autophagy in Human Hepatocellular Carcinoma
Ke Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Paclitaxel/Tetrandrine Coloaded Nanoparticles Effectively Promote the Apoptosis of Gastric Cancer Cells Based on Oxidation Therapy
Xiaolin Li et al.
MOLECULAR PHARMACEUTICS (2012)
Preparation, Characterization, Pharmacokinetics and Tissue Distribution of Solid Lipid Nanoparticles Loaded with Tetrandrine
Su Li et al.
AAPS PHARMSCITECH (2011)
Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer's disease induced by amyloid-β(1-42)
Fu-Qian He et al.
BRAIN RESEARCH (2011)
Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo
Yuxing Zhang et al.
CANCER LETTERS (2011)
β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation
Kyung-Ran Park et al.
CANCER LETTERS (2011)
The pharmacokinetical study of plant alkaloid tetrandrine with a simple HPLC method in rabbits
Xin-Hui Jiang et al.
FITOTERAPIA (2011)
Marine natural products: a new wave of drugs?
Rana Montaser et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells
Baoan Chen et al.
HEMATOLOGY (2011)
From branch to bedside: Youyou Tu is awarded the 2011 Lasker∼DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria
Ushma S. Neill
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tetrandrine Induces Apoptosis and Triggers Caspase Cascade in Human Bladder Cancer Cells
Xudong Li et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer
Bai-Cheng He et al.
MOLECULAR PHARMACOLOGY (2011)
The Potential of Tetrandrine as a Protective Agent for Ischemic Stroke
Yun Chen et al.
MOLECULES (2011)
Developments in cancer prevention and treatment using traditional Chinese medicine
Hongsheng Lin et al.
Frontiers of Medicine (2011)
Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro
Wei Xu et al.
Cancers (2011)
Reversal Effect of Stephania Tetrandra-Containing Chinese Herb Formula SENL on Multidrug Resistance in Lung Cancer Cell Line SW1573/2R120
Meng Xu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2010)
Involvement of PI3K/AKT/GSK3ß pathway in tetrandrine-induced G1 arrest and apoptosis
Xuan Li Chen et al.
CANCER BIOLOGY & THERAPY (2010)
Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway
Chye-Sun Ong et al.
CANCER LETTERS (2010)
Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice
Jiann-Ming Wu et al.
CANCER LETTERS (2010)
Enhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells - A possible Trojan strategy against cancer
Xiaolin Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription
Huiling Shen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Lactoferrin-Conjugated Biodegradable Polymersome Holding Doxorubicin and Tetrandrine for Chemotherapy of Glioma Rats
Zhiqing Pang et al.
MOLECULAR PHARMACEUTICS (2010)
Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells
Zhixiang Cheng et al.
PHYTOMEDICINE (2010)
The Role of Traditional Chinese Herbal Medicines in Cancer Therapy - from TCM Theory to Mechanistic Insights
W. L. Wendy Hsiao et al.
PLANTA MEDICA (2010)
Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats
Yun Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery
Rutian Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Role of nanocarrier systems in cancer nanotherapy
M. R. Mozafari et al.
JOURNAL OF LIPOSOME RESEARCH (2009)
Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells
Hyun Sun Cho et al.
JOURNAL OF VETERINARY SCIENCE (2009)
Neural cell cycle dysregulation and central nervous system diseases
Wei Wang et al.
PROGRESS IN NEUROBIOLOGY (2009)
GSK-3β is a critical mediator of tetrandrine induced cell cycle arrest and cytotoxicity -: Commentary
James A. McCubrey et al.
CANCER BIOLOGY & THERAPY (2008)
Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids
Baorui Liu et al.
CANCER LETTERS (2008)
Establishment of a liquid chromatographic/mass spectrometry method for quantification of tetrandrine in rat plasma and its application to pharmacokinetic study
Naining Song et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines
Jia Wei et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice
Chun-Ling Dai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Apoptosis signaling pathways and lymphocyte homeostasis
Guangwu Xu et al.
CELL RESEARCH (2007)
Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia
WL Xu et al.
LEUKEMIA RESEARCH (2006)
Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines
LT Ng et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2006)
Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-β in vitro via up-regulation of Smad 7
YW Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell
SY Chor et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine
J Jin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Tetrandrine induces apoptosis in hepatic stellate cells
YZ Zhao et al.
PHYTOTHERAPY RESEARCH (2004)
Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1
LH Meng et al.
CANCER RESEARCH (2004)
Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-δ in U937 cells
BC Jang et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Inhibitory effect of tetrandrine on pulmonary metastases in CT26 colorectal adenocarcinoma-bearing BALB/c mice
KH Chang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2004)
Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release
SH Oh et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells
PL Kuo et al.
LIFE SCIENCES (2003)
Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in Neuro 2a mouse neuroblastoma cells
Q Jin et al.
LIFE SCIENCES (2002)
Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells
SM Yoo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2002)
The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinorna MCF-7/adr cells
LW Fu et al.
EUROPEAN JOURNAL OF CANCER (2002)
Share Paper
